Fundraising Fox

Alector

NASDAQ: ALEC

San Francisco, US · Founded 2013 · Delaware LLC · 6 known investors

alector.com ↗

Alector develops therapies targeting neurodegenerative diseases including Alzheimer's, frontotemporal dementia, and Parkinson's disease through protein removal, replacement, and immune cell restoration. The company focuses on patients with neurodegenerative conditions and applies genetics, neuroscience, and immunology to advance new treatments.

AI & Machine LearningBiotechHealthtechLongevityMedical Devicesin /alector@AlectorTx

Founders & leadership

ARArnon Rosenthal
Arnon RosenthalPh.D.
CG
Carl GordonDirector
TG
Tillman GerngrossDirector
TM
Terry McGuireDirector

Investors · 6

Foresite CapitalLarkspur
Mission Bay CapitalSan Francisco
Mission BiocapitalSan Francisco · $500K
MRL Ventures FundCambridge · $25M
SV Health InvestorsBoston · $1M – $20M
Polaris PartnersreportedBoston · $500K – $5Mvia Terry McGuire · board

Reported raises · per SEC filings

Form D private placements
▶$32.3MraisedSep 2015 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Carl GordonDirector
  • Tillman GerngrossDirector
  • Arnon RosenthalExecutive Officer, Director
  • Terry McGuireDirector
Offering amount
$32.3M
Amount sold
$32.3M
First sale
Sep 2015
Incorporated
Limited Liability Company, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news